Europe Drug Delivery Market Developments, Trends and Opportunities, Forecast by 2028
According to Business Market Insights research, the Europe Drug Delivery Market was valued at US$ 6,32,268.46 million in 2023 and is expected to reach US$ 8,95,338.87 million by 2028, registering a CAGR of 7.2% from 2023 to 2028. Rising incidence of chronic diseases, growing demand for noninvasive drug delivery systems, and increasing R&D expenditures in pharmaceutical companies are the critical factors attributed to the Europe drug delivery market expansion.
Download Sample PDF Copy: https://www.businessmarketinsights.com/sample/BMIRE00028754
The List of Companies - Europe Drug Delivery Market
- Bausch Health Companies Inc
- Baxter International Inc
- Becton Dickinson and Co
- Boehringer Ingelheim International GmbH
- Boston Scientific Corp
- Gerresheimer AG
- GlaxoSmithKline Plc
- Johnson & Johnson
- Novartis AG
- Novo Nordisk AS
- Pfizer Inc
- Sever Pharma Solutions
Europe Drug Delivery Market: Advancements in Noninvasive Drug Delivery Systems
Surging Demand for Noninvasive Drug Delivery Methods
Noninvasive drug delivery refers to the painless administration of medications through biological barriers such as mucosal surfaces or the skin. This innovative drug delivery approach enhances access to medicines, improves patient adherence, and promotes a better safety profile compared to traditional injection-based methods. The preference for noninvasive drug delivery is increasing due to its higher patient compliance, as it minimizes pain and discomfort during administration.
Advancements in medical devices and transdermal technologies have positioned noninvasive drug delivery systems as a strong competitor to traditional oral and injectable routes. Popular noninvasive delivery methods include:
🔹 Topical & transdermal (passive and active) drug delivery
🔹 Trans-ocular and trans-mucosal membrane absorption
🔹 Alveolar membrane delivery via inhaled medications
The growing interest in transdermal drug delivery systems (TDDS) is driven by their low rejection rate, ease of use, convenience, and efficiency. Besides pharmaceutical applications, TDDS is increasingly utilized in the skincare and cosmetic industry for localized drug administration, preventing nonspecific drug delivery to unintended tissues.
📌 Potential Applications of TDDS:
✔ Management of cardiovascular and central nervous system disorders
✔ Treatment of genetic and neuromuscular disorders
✔ Infectious disease management and localized treatment solutions
✔ Advancements in vaccination and self-administered long-term therapies
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications
Author’s Bio:
Suryakant Gadekar
Senior Market Research Expert at Business Market Insights
Comments
Post a Comment